{"count":34,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+3788&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/d382efdf-4f13-4d42-a2e9-8e476aa54f45/","filing_uuid":"d382efdf-4f13-4d42-a2e9-8e476aa54f45","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/d382efdf-4f13-4d42-a2e9-8e476aa54f45/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Amy Shank","dt_posted":"2026-04-20T12:22:15-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"9901 S. Wilcrest Dr","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Houston","registrant_state":"TX","registrant_zip":"77099","registrant":{"id":401103386,"url":"https://lda.gov/api/v1/registrants/401103386/","house_registrant_id":null,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","description":"Membership organization providing resources to independent compounding pharmacies","address_1":"9901 S. Wilcrest Dr","address_2":null,"address_3":null,"address_4":null,"city":"Houston","state":"TX","state_display":"Texas","zip":"77099","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY SHANK","contact_telephone":"+1 202-412-0412","dt_updated":"2026-07-24T14:07:59.280567-04:00"},"client":{"id":198794,"url":"https://lda.gov/api/v1/clients/198794/","client_id":12,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-07-21"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025; S. 3794 / H.R. 6509, The Safe Drugs Act; S. 3788, The Clear Labels Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1418a58b-0775-4e45-9b77-06e8109c2656/","filing_uuid":"1418a58b-0775-4e45-9b77-06e8109c2656","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1418a58b-0775-4e45-9b77-06e8109c2656/print/","filing_document_content_type":"text/html","income":null,"expenses":"12210000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-04-20T13:06:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law No. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law No. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law No. 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No. 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Biopharmaceutical innovation policy issues SECURE Rx Act of 2026 (draft) User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (Public Law No. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1005,"prefix":null,"prefix_display":null,"first_name":"STEVE","nickname":null,"middle_name":null,"last_name":"TILTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/4ef39b54-7a3f-46d2-a4de-8541d459e25a/","filing_uuid":"4ef39b54-7a3f-46d2-a4de-8541d459e25a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/4ef39b54-7a3f-46d2-a4de-8541d459e25a/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Gary Gallant","dt_posted":"2026-04-20T14:26:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"253 36th Street","registrant_address_2":"STE C663","registrant_different_address":false,"registrant_city":"Brooklyn","registrant_state":"NY","registrant_zip":"11232","registrant":{"id":401110201,"url":"https://lda.gov/api/v1/registrants/401110201/","house_registrant_id":77363,"name":"BLUEFORS INC.","description":null,"address_1":"253 36th Street","address_2":"STE C663","address_3":null,"address_4":null,"city":"Brooklyn","state":"NY","state_display":"New York","zip":"11232","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GARY GALLANT","contact_telephone":"+1 202-492-3636","dt_updated":"2026-07-15T08:51:55.140473-04:00"},"client":{"id":70814,"url":"https://lda.gov/api/v1/clients/70814/","client_id":70814,"name":"BLUEFORS INC.","general_description":"Cryogenics Technology Supplier","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-01-01"},"lobbying_activities":[{"general_issue_code":"CPI","general_issue_code_display":"Computer Industry","description":"Quantum computing as related to cloud infrastructure.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Quantum cryptography research and application matters, including provisions in S. 3597, the National Quantum Initiative Reauthorization act of 2026.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"Quantum cryptography research and application matters, including provisions in S. 3597, the National Quantum Initiative Reauthorization act of 2026.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":150,"name":"Federal Bureau of Investigation (FBI)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Encouraging further cryogenic workforce and manufacturing capacity in the United States, including provisions in S. 1343, the Advancing Quantum Manufacturing Act of 2025.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Quantum computing policy and research, including provisions in S. 579 - Department of Energy Quantum Leadership Act of 2025, S. 1746/HR 5712 - Quantum LEAP Act of 2025, S. 4163/H.R. 6351 - Advancing Regional Quantum Hubs Act, S. 1397 - International Quantum Research Exchange Act, S. 1343 - Advancing Quantum Manufacturing Act of 2025, H.R. 3788 - Support for Quantum Supply Chains Act, S. 3597 - National Quantum Initiative Reauthorization Act of 2026","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Trade and bilateral discussions with Finland. Tariffs on inputs and finished goods.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/eeadef9c-2fdc-4169-8e10-40021d3ed06b/","filing_uuid":"eeadef9c-2fdc-4169-8e10-40021d3ed06b","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/eeadef9c-2fdc-4169-8e10-40021d3ed06b/print/","filing_document_content_type":"text/html","income":null,"expenses":"320000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"William Tighe","dt_posted":"2026-04-20T14:31:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1776 Wilson Blvd.","registrant_address_2":"Suite 200","registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22209","registrant":{"id":26672,"url":"https://lda.gov/api/v1/registrants/26672/","house_registrant_id":30239,"name":"NATIONAL ASSOCIATION OF CHAIN DRUG STORES","description":null,"address_1":"1776 Wilson Blvd","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22209","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID FITZSIMMONS","contact_telephone":"+1 703-549-3001","dt_updated":"2026-08-31T11:07:32.463699-04:00"},"client":{"id":134215,"url":"https://lda.gov/api/v1/clients/134215/","client_id":12,"name":"NATIONAL ASSOCIATION OF CHAIN DRUG STORES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-26"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 7148 Consolidated Appropriations Act, 2026 H.R. 2484 Seniors Access to Critical Medications Act H.R. 2853 Combating Organized Retail Crime Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2426 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act H.R. 5256 340B ACCESS Act H.R. 4581 340B PATIENTS Act S. 2372 340B PATIENTS Act H.R. 6400 Rx ACCESS Act S. 4106 Rx ACCESS Act S. 3788 CLEAR LABELS Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41242,"prefix":"mr","prefix_display":"MR.","first_name":"KEVIN","nickname":null,"middle_name":"N","last_name":"NICHOLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":16508,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"C","last_name":"ANDERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65079,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"TIGHE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101990,"prefix":null,"prefix_display":null,"first_name":"CHRISTIE","nickname":null,"middle_name":"R.","last_name":"BOUTTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138115,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"PATRICK","last_name":"KRESE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":108774,"prefix":null,"prefix_display":null,"first_name":"KAYLA","nickname":null,"middle_name":null,"last_name":"MCFEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140214,"prefix":null,"prefix_display":null,"first_name":"KATE","nickname":null,"middle_name":null,"last_name":"ILAHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150625,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 7148 Consolidated Appropriations Act, 2026 H.R. 2484 Seniors Access to Critical Medications Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 2626 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41242,"prefix":"mr","prefix_display":"MR.","first_name":"KEVIN","nickname":null,"middle_name":"N","last_name":"NICHOLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":16508,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"C","last_name":"ANDERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65079,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"TIGHE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101990,"prefix":null,"prefix_display":null,"first_name":"CHRISTIE","nickname":null,"middle_name":"R.","last_name":"BOUTTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138115,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"PATRICK","last_name":"KRESE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":108774,"prefix":null,"prefix_display":null,"first_name":"KAYLA","nickname":null,"middle_name":null,"last_name":"MCFEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140214,"prefix":null,"prefix_display":null,"first_name":"KATE","nickname":null,"middle_name":null,"last_name":"ILAHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150625,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 7148 Consolidated Appropriations Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65079,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"TIGHE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41242,"prefix":"mr","prefix_display":"MR.","first_name":"KEVIN","nickname":null,"middle_name":"N","last_name":"NICHOLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":16508,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"C","last_name":"ANDERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101990,"prefix":null,"prefix_display":null,"first_name":"CHRISTIE","nickname":null,"middle_name":"R.","last_name":"BOUTTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138115,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"PATRICK","last_name":"KRESE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":108774,"prefix":null,"prefix_display":null,"first_name":"KAYLA","nickname":null,"middle_name":null,"last_name":"MCFEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140214,"prefix":null,"prefix_display":null,"first_name":"KATE","nickname":null,"middle_name":null,"last_name":"ILAHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150625,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6f4ebeac-0efa-4edc-8892-1e6bf4912581/","filing_uuid":"6f4ebeac-0efa-4edc-8892-1e6bf4912581","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/6f4ebeac-0efa-4edc-8892-1e6bf4912581/print/","filing_document_content_type":"text/html","income":null,"expenses":"2580000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jesse Kerns","dt_posted":"2026-04-20T16:12:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":3867,"url":"https://lda.gov/api/v1/registrants/3867/","house_registrant_id":31560,"name":"AMGEN, INC.","description":null,"address_1":"601 13th Street, NW","address_2":"11th Floor North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREG PORTNER","contact_telephone":"+1 202-585-9500","dt_updated":"2026-07-30T12:38:37.840722-04:00"},"client":{"id":103709,"url":"https://lda.gov/api/v1/clients/103709/","client_id":12,"name":"AMGEN INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act H.R.5526 Biosimilar Red Tape Elimination Act HR 7391 Community Health Center Drug Pricing Protection Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S.3345, PBM Price Transparency and Accountability Act HR 6166, Lowering Drug Costs for American Families Act S 3019 - No Big Blockbuster Bailouts Act S 3349 PBM Disclosure Act HR 4317 PBM Reform Act Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act (EPIC) HR 1672 Maintaining Investments in New Innovation Act (MINI) HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 PL 119-75 Consolidated Appropriations Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international tax Public Law 115-97, Tax Cuts and Jobs Act Public Law 119-21, One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) Issues related to Puerto Rico Issues related to OECD negotiations on the taxation of global income","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cf6cd7a5-d6ee-4ed0-b861-047a616e7182/","filing_uuid":"cf6cd7a5-d6ee-4ed0-b861-047a616e7182","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/cf6cd7a5-d6ee-4ed0-b861-047a616e7182/print/","filing_document_content_type":"text/html","income":"450000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Krista Hessler Carver","dt_posted":"2026-04-20T16:12:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"850 Tenth Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":11195,"url":"https://lda.gov/api/v1/registrants/11195/","house_registrant_id":31827,"name":"COVINGTON & BURLING LLP","description":"Law firm","address_1":"850 10th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS XENAKIS","contact_telephone":"+1 202-662-5846","dt_updated":"2026-07-29T10:42:26.460623-04:00"},"client":{"id":115000,"url":"https://lda.gov/api/v1/clients/115000/","client_id":467,"name":"PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64759,"prefix":null,"prefix_display":null,"first_name":"KRISTA","nickname":null,"middle_name":null,"last_name":"CARVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98248,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"DERZKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Biosimilars Access and Affordability Act (S. 5459); Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269); Expedited Access to Biosimilars Act (S. 1414); Biosimilar Red Tape Elimination Act (S. 1954/H.R. 5526); CLEAR Act (H.R.7140); Artificial Intelligence-Ready Data Act (S.4098); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); Drug Competition Enhancement Act (S.1040); America's Living Library Project Bill (S. 4023); Securing Essential Components for U.S. Readiness in Essential Pharmaceuticals (SECURE Rx) Act of 2026 (discussion draft); improvements to the National Childhood Vaccine Injury Act of 1986; Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act (S. 3788).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64759,"prefix":null,"prefix_display":null,"first_name":"KRISTA","nickname":null,"middle_name":null,"last_name":"CARVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":119967,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20900,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"L","last_name":"PLITSCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20743,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"F","last_name":"KINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98248,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"DERZKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69156,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"COSGROVE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/391b60b5-fbc2-4269-b86a-fdcc6853578e/","filing_uuid":"391b60b5-fbc2-4269-b86a-fdcc6853578e","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/391b60b5-fbc2-4269-b86a-fdcc6853578e/print/","filing_document_content_type":"text/html","income":null,"expenses":"470000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Anne O. Riser","dt_posted":"2026-04-20T17:03:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"200 MASSACHUSETTS AVENUE, NW","registrant_address_2":"SUITE 310","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":7554,"url":"https://lda.gov/api/v1/registrants/7554/","house_registrant_id":31585,"name":"BUSINESS SOFTWARE ALLIANCE","description":null,"address_1":"200 MASSACHUSETTS AVENUE, NW","address_2":"SUITE 310","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNE RISER","contact_telephone":"+1 202-530-5148","dt_updated":"2026-07-16T15:45:10.679271-04:00"},"client":{"id":110754,"url":"https://lda.gov/api/v1/clients/110754/","client_id":12,"name":"BUSINESS SOFTWARE ALLIANCE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-30"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues pertaining to intellectual property rights including, but not limited to, patent protection and enforcement, copyright protection and enforcement in international markets, and including S. 1553 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":207,"name":"U.S. Copyright Office"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Issues pertaining to workforce development and retraining issues, S. 2976 - Halting International Relocation of Employment (HIRE) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"INT","general_issue_code_display":"Intelligence","description":"Issues related to intelligence community surveillance of electronic communications","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues pertaining to market access for software products and services in international markets including, but not limited to, provisions related to intellectual property protection and market access for software products and services, S. 3399 - Digital Trade Promotion Act of 2025 Issues pertaining to international trade agreements including, but not limited to, provisions relating to IP protection and enforcement, electronic commerce, services and government procurement, including H.R. 2683 - Remote Access Security Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"National Defense Authorization Act generally, and including the House FY26 NDAA, S. 2296 - the Senate FY26 NDAA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145016,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"SALMOIRAGHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Domestic law enforcement access to digital evidence generally, S. 3663/H.R. 6048 NDO Fairness Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPI","general_issue_code_display":"Computer Industry","description":"Issues related to modernization of government technology generally, including FedRAMP Issues related to quantum technology, including S. 1344/H.R. 3220 - Quantum Sandbox for Near-Term Applications Act of 2025, S. 1746 - Quantum LEAP Act of 2025, H.R. 3788 - Support for Quantum Supply Chains Act, S. 2558 - The National Quantum Cybersecurity Migration Strategy Act of 2025, H.R. 4942 - Quantum Encryption Readiness and Resilience Act, S.3597 National Quantum Initiative Reauthorization Act of 2026 Issues pertaining to Cybersecurity generally, and including H.R. 1000 - Cyber PIVOTT Act, S. 1337 - Cybersecurity Information Sharing Extension Act Issues pertaining to the development of Artificial Intelligence generally, and specifically, S. 146 - TAKE IT DOWN Act, H.R. 633 - TAKE IT DOWN Act, H.R. 2385 - CREATE AI Act, S. 1792 - AI Whistleblower Protection Act, S. 2081 - RISE Act of 2025, H.R. 4142 - Adversarial AI Act of 2025, S. 2750 - SANDBOX Act, S. 3150 - GAIN AI Act, H.R. 6875 - Overwatch AI Act Issues pertaining to government procurement of software generally, and including the FoRGED Act, the Safeguarding American Innovation Act, H.R. 2417 - Strengthening Agency Management and Oversight of Software Assets Act, S. 1362/H.R. 2765 - SAFE Supply Chains Act, H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery (SPEED) Act, H.R. 3961 - Safeguarding American Innovation Act, H.R. 7604 Contracting America First Act Comprehensive federal privacy legislation, generally and including S. 836 - Children and Teens Online Privacy Protection Act, S. 1748 - Kids Online Safety Act Issues pertaining to content moderation and Section 230 generally","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145016,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"SALMOIRAGHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7d4cedf1-9279-41b4-98db-f1f8e29a1309/","filing_uuid":"7d4cedf1-9279-41b4-98db-f1f8e29a1309","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/7d4cedf1-9279-41b4-98db-f1f8e29a1309/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mary Beth Savary Taylor","dt_posted":"2026-04-20T17:49:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":213700,"url":"https://lda.gov/api/v1/clients/213700/","client_id":1005608,"name":"AMGEN","general_description":"Biotechnology.","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored implementation of P.L. 117-169, the Inflation Reduction Act as it relates to drug pricing. Issues related to biosimilars. Monitored issues related to cardiovascular health. Issues related to pharmacy benefit management. Monitored issues related to dialysis services. Issues related to the Most Favored Nation drug pricing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to pharmacy benefit management. Issues related to cardiovascular care. Issues related to drug pricing. Issues related to the drug supply chain. S. 3788, Clear Labels Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Monitored issues related to intellectual property.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51079,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"CHOUDHRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/fae3d903-9159-4426-9f44-1985a2a7b186/","filing_uuid":"fae3d903-9159-4426-9f44-1985a2a7b186","filing_type":"1T","filing_type_display":"1st Quarter - Termination","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/fae3d903-9159-4426-9f44-1985a2a7b186/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mike Nielsen","dt_posted":"2026-04-20T18:11:03-04:00","termination_date":"2026-03-02","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1307 New York Ave., NW Suite 600","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":76992,"url":"https://lda.gov/api/v1/registrants/76992/","house_registrant_id":36118,"name":"CGCN GROUP, LLC","description":"Public Affairs Consultants","address_1":"1307 New York Ave., NW Suite 600","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVE CLARK","contact_telephone":"+1 202-628-0028","dt_updated":"2026-07-12T16:09:24.002258-04:00"},"client":{"id":169766,"url":"https://lda.gov/api/v1/clients/169766/","client_id":1002781,"name":"BSA THE SOFTWARE ALLIANCE (FORMERLY BSA BUSINESS SOFTWARE ALLIANCE INC)","general_description":"Technology Association","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-01-01"},"lobbying_activities":[{"general_issue_code":"CPI","general_issue_code_display":"Computer Industry","description":"Issues related to modernization of government technology generally, including FedRAMP; Issues related to quantum technology, including S. 1344/H.R. 3220 - Quantum Sandbox for Near-Term Applications Act of 2025, S. 1746 - Quantum LEAP Act of 2025, H.R. 3788 - Support for Quantum Supply Chains Act, S. 2558 - The National Quantum Cybersecurity Migration Strategy Act of 2025, H.R. 4942 - Quantum Encryption Readiness and Resilience Act; Issues pertaining to Cybersecurity generally, and including H.R. 1000 - Cyber PIVOTT Act, S. 1337 - Cybersecurity Information Sharing Extension Act; Issues pertaining to the development of Artificial Intelligence generally, and specifically, S. 146 - TAKE IT DOWN Act, H.R. 633 - TAKE IT DOWN Act, H.R. 2385 - CREATE AI Act, S. 1792 - AI Whistleblower Protection Act, S. 2081 - RISE Act of 2025, H.R. 4142 - Adversarial AI Act of 2025, S. 2750 - SANDBOX Act, S. 3150 - GAIN AI Act; Issues pertaining to government procurement of software generally, and including, the FoRGED Act, the Safeguarding American Innovation Act, H.R. 2417 - Strengthening Agency Management and Oversight of Software Assets Act, S. 1362/H.R. 2765 - SAFE Supply Chains Act, H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery (SPEED) Act, H.R. 3961 - Safeguarding American Innovation Act; Comprehensive federal privacy legislation, generally and including S. 836 - Children and Teens Online Privacy Protection Act, S. 1748 - Kids Online Safety Act; Issues pertaining to content moderation and Section 230 generally including.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36872,"prefix":null,"prefix_display":null,"first_name":"SAM","nickname":null,"middle_name":null,"last_name":"GEDULDIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63838,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STIPICEVIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72857,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"RIPLINGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues pertaining to market access for software products and services in international markets including, but not limited to, provisions related to intellectual property protection and market access for software products and services. Issues pertaining to international trade agreements including, but not limited to, provisions relating to IP protection and enforcement, electronic commerce, services and government procurement, including H.R. 2683 - Remote Access Security Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36872,"prefix":null,"prefix_display":null,"first_name":"SAM","nickname":null,"middle_name":null,"last_name":"GEDULDIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63838,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STIPICEVIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72857,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"RIPLINGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"National Defense Authorization Act generally, and including the House FY26 NDAA, S. 2296 - Senate FY26 NDAA.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36872,"prefix":null,"prefix_display":null,"first_name":"SAM","nickname":null,"middle_name":null,"last_name":"GEDULDIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63838,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STIPICEVIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72857,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"RIPLINGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues pertaining to intellectual property rights including, but not limited to, patent protection and enforcement, copyright protection and enforcement in international markets, and including S. 1553 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36872,"prefix":null,"prefix_display":null,"first_name":"SAM","nickname":null,"middle_name":null,"last_name":"GEDULDIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63838,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STIPICEVIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72857,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"RIPLINGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Issues pertaining to workforce development and retraining issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36872,"prefix":null,"prefix_display":null,"first_name":"SAM","nickname":null,"middle_name":null,"last_name":"GEDULDIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63838,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STIPICEVIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72857,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"RIPLINGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INT","general_issue_code_display":"Intelligence","description":"Issues related to intelligence community surveillance of electronic communications.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36872,"prefix":null,"prefix_display":null,"first_name":"SAM","nickname":null,"middle_name":null,"last_name":"GEDULDIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72857,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"RIPLINGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63838,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STIPICEVIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Domestic law enforcement access to digital evidence generally.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36872,"prefix":null,"prefix_display":null,"first_name":"SAM","nickname":null,"middle_name":null,"last_name":"GEDULDIG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72857,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"RIPLINGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63838,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STIPICEVIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2c5d0123-1385-41b5-aa02-7303db5efcbf/","filing_uuid":"2c5d0123-1385-41b5-aa02-7303db5efcbf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2c5d0123-1385-41b5-aa02-7303db5efcbf/print/","filing_document_content_type":"text/html","income":null,"expenses":"1640000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-04-20T21:36:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (P.L. 119-28) H.R. 3944: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 4213: Department of Homeland Security Appropriations Act, 2026 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75), Provisions related to the pharmaceutical industry. Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 708: RESTORE Patent Rights Act of 2025 S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 1574: RESTORE Patent Rights Act of 2025 H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: H.R. 1492, Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025. To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Section 340B Public Health Services Act 340B engagement and MFN related engagement Provisions related to the 340B program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements Biopharmaceutical innovation and pricing issues HR 5509, Safe Step Act, Provisions related step therapy protocols Tariff and MFN issues VICP Bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) S. 1637: MVP Act Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues China outbound investment policy issues US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f5d6311c-a068-40fd-9f03-d203b4e9a658/","filing_uuid":"f5d6311c-a068-40fd-9f03-d203b4e9a658","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/f5d6311c-a068-40fd-9f03-d203b4e9a658/print/","filing_document_content_type":"text/html","income":null,"expenses":"110000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Tim Casey","dt_posted":"2026-04-20T22:42:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12601 Twinbrook Parkway","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":400358632,"url":"https://lda.gov/api/v1/registrants/400358632/","house_registrant_id":null,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","description":"Public health organization","address_1":"12601 Twinbrook Parkway","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY P. LAKAVAGE","contact_telephone":"+1 301-816-8334","dt_updated":"2026-07-30T11:25:36.781811-04:00"},"client":{"id":189520,"url":"https://lda.gov/api/v1/clients/189520/","client_id":12,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ba228f5a-3f49-4e5b-9fa7-0ab3b00cb557/","filing_uuid":"ba228f5a-3f49-4e5b-9fa7-0ab3b00cb557","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/ba228f5a-3f49-4e5b-9fa7-0ab3b00cb557/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Gary Gallant","dt_posted":"2026-07-10T16:26:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"253 36th Street","registrant_address_2":"STE C663","registrant_different_address":false,"registrant_city":"Brooklyn","registrant_state":"NY","registrant_zip":"11232","registrant":{"id":401110201,"url":"https://lda.gov/api/v1/registrants/401110201/","house_registrant_id":77363,"name":"BLUEFORS INC.","description":null,"address_1":"253 36th Street","address_2":"STE C663","address_3":null,"address_4":null,"city":"Brooklyn","state":"NY","state_display":"New York","zip":"11232","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GARY GALLANT","contact_telephone":"+1 202-492-3636","dt_updated":"2026-07-15T08:51:55.140473-04:00"},"client":{"id":70814,"url":"https://lda.gov/api/v1/clients/70814/","client_id":70814,"name":"BLUEFORS INC.","general_description":"Cryogenics Technology Supplier","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-01-01"},"lobbying_activities":[{"general_issue_code":"CPI","general_issue_code_display":"Computer Industry","description":"Quantum computing as related to cloud infrastructure.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Quantum cryptography research and application matters, including provisions in S. 3597, the National Quantum Initiative Reauthorization act of 2026. Executive Order 14412 - Securing the Nation Against Advanced Cryptographic Attacks.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"Quantum cryptography research and application matters, including provisions in S. 3597, the National Quantum Initiative Reauthorization act of 2026. Executive Order 14412 - Securing the Nation Against Advanced Cryptographic Attacks.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":150,"name":"Federal Bureau of Investigation (FBI)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Encouraging further cryogenic workforce and manufacturing capacity in the United States, including provisions in S. 1343, the Advancing Quantum Manufacturing Act of 2025 and S. 579, the Department of Energy Quantum Leadership Act of 2025.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Quantum computing policy and research, including provisions in S. 579 - Department of Energy Quantum Leadership Act of 2025, S. 1746/HR 5712 - Quantum LEAP Act of 2025, S. 4163/H.R. 6351 - Advancing Regional Quantum Hubs Act, S. 1397 - International Quantum Research Exchange Act, S. 1343 - Advancing Quantum Manufacturing Act of 2025, H.R. 3788 - Support for Quantum Supply Chains Act, S. 3597 - National Quantum Initiative Reauthorization Act of 2026, and S. 579, the Department of Energy Quantum Leadership Act of 2025. Executive Order 14413 \"Ushering in the Next Frontier of Quantum Innovation\"","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Trade and bilateral discussions with Finland. Tariffs on inputs and finished goods.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/390f4450-f988-4fdc-bf59-907f27a2dbad/","filing_uuid":"390f4450-f988-4fdc-bf59-907f27a2dbad","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/390f4450-f988-4fdc-bf59-907f27a2dbad/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Diane Major","dt_posted":"2026-07-10T17:36:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Ave., NW, Suite 300","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington, DC","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401103162,"url":"https://lda.gov/api/v1/registrants/401103162/","house_registrant_id":null,"name":"THE D MAJOR GROUP","description":"Government affairs consulting","address_1":"300 New Jersey Ave., NW, Suite 300","address_2":null,"address_3":null,"address_4":null,"city":"Washington, DC","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DIANE MAJOR","contact_telephone":"+1 202-695-0635","dt_updated":"2026-07-14T14:03:47.385236-04:00"},"client":{"id":198055,"url":"https://lda.gov/api/v1/clients/198055/","client_id":63,"name":"HEALTH CARE SUPPLY CHAIN ASSOCIATION","general_description":"Trade association representing healthcare provider group purchasing organizations.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-10-28"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Work on protection of the Medicare safe harbor and its savings to the health care delivery system.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Senate Republican Policy Committee","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conference","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Work on drug shortage issues affecting outpatient and inpatient settings. Also work on drug visibility supply chain issues including S. 3788, \"the CLEAR Labels Act.\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Senate Republican Policy Committee","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conference","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Work on incentives for onshore manufacturing, in addition to an emergency exemption for critical medical supplies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Sen. Repub. Policy Com't.","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conf.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67b5714f-7362-43a2-86fd-22759280fe17/","filing_uuid":"67b5714f-7362-43a2-86fd-22759280fe17","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67b5714f-7362-43a2-86fd-22759280fe17/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-07-16T16:09:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S._____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. ___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/0b40eb79-fb41-4351-982f-6ad1e3f21942/","filing_uuid":"0b40eb79-fb41-4351-982f-6ad1e3f21942","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0b40eb79-fb41-4351-982f-6ad1e3f21942/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Amy Shank","dt_posted":"2026-07-20T14:33:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"9901 S. Wilcrest Dr","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Houston","registrant_state":"TX","registrant_zip":"77099","registrant":{"id":401103386,"url":"https://lda.gov/api/v1/registrants/401103386/","house_registrant_id":null,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","description":"Membership organization providing resources to independent compounding pharmacies","address_1":"9901 S. Wilcrest Dr","address_2":null,"address_3":null,"address_4":null,"city":"Houston","state":"TX","state_display":"Texas","zip":"77099","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY SHANK","contact_telephone":"+1 202-412-0412","dt_updated":"2026-07-24T14:07:59.280567-04:00"},"client":{"id":198794,"url":"https://lda.gov/api/v1/clients/198794/","client_id":12,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-07-21"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154528,"prefix":null,"prefix_display":null,"first_name":"CLAIRE","nickname":null,"middle_name":null,"last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":"Intern, Congressman Jim Himes - 9/21 - 12/21; Intern, House Appropriations Committee, Subcommittee on Homeland Security - 1/22 - 5/22; Intern, Senator Richard Blumenthal - 5/22 - 7/22; Intern, Congressman Jamie Raskin - 7/22 - 8/22","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025; S. 3794 / H.R. 6509, The Safe Drugs Act; S. 3788/ H.R. 8269 The Clear Labels Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154528,"prefix":null,"prefix_display":null,"first_name":"CLAIRE","nickname":null,"middle_name":null,"last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":"Intern, Congressman Jim Himes - 9/21 - 12/21; Intern, House Appropriations Committee, Subcommittee on Homeland Security - 1/22 - 5/22; Intern, Senator Richard Blumenthal - 5/22 - 7/22; Intern, Congressman Jamie Raskin - 7/22 - 8/22","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154528,"prefix":null,"prefix_display":null,"first_name":"CLAIRE","nickname":null,"middle_name":null,"last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":"Intern, Congressman Jim Himes - 9/21 - 12/21; Intern, House Appropriations Committee, Subcommittee on Homeland Security - 1/22 - 5/22; Intern, Senator Richard Blumenthal - 5/22 - 7/22; Intern, Congressman Jamie Raskin - 7/22 - 8/22","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/73b8a3f6-d1e2-4a7c-850f-da9b0de8dc2d/","filing_uuid":"73b8a3f6-d1e2-4a7c-850f-da9b0de8dc2d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/73b8a3f6-d1e2-4a7c-850f-da9b0de8dc2d/print/","filing_document_content_type":"text/html","income":null,"expenses":"290000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"William Tighe","dt_posted":"2026-07-20T15:30:55-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1776 Wilson Blvd.","registrant_address_2":"Suite 200","registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22209","registrant":{"id":26672,"url":"https://lda.gov/api/v1/registrants/26672/","house_registrant_id":30239,"name":"NATIONAL ASSOCIATION OF CHAIN DRUG STORES","description":null,"address_1":"1776 Wilson Blvd","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22209","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID FITZSIMMONS","contact_telephone":"+1 703-549-3001","dt_updated":"2026-08-31T11:07:32.463699-04:00"},"client":{"id":134215,"url":"https://lda.gov/api/v1/clients/134215/","client_id":12,"name":"NATIONAL ASSOCIATION OF CHAIN DRUG STORES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-26"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 2484 Seniors Access to Critical Medications Act H.R. 2853 Combating Organized Retail Crime Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2426 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act H.R. 5256 340B ACCESS Act H.R. 4581 340B PATIENTS Act S. 2372 340B PATIENTS Act H.R. 6400 Rx ACCESS Act S. 4106 Rx ACCESS Act S. 3788 CLEAR LABELS Act S. 4509 Patients Before Monopolies Act H.R. 8779 Patients Before Monopolies Act S. 3822 Break Up Big Medicine Act H.R. 8800 National Defense Authorization Act S. 4784 National Defense Authorization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41242,"prefix":"mr","prefix_display":"MR.","first_name":"KEVIN","nickname":null,"middle_name":"N","last_name":"NICHOLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":16508,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"C","last_name":"ANDERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65079,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"TIGHE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101990,"prefix":null,"prefix_display":null,"first_name":"CHRISTIE","nickname":null,"middle_name":"R.","last_name":"BOUTTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138115,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"PATRICK","last_name":"KRESE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":108774,"prefix":null,"prefix_display":null,"first_name":"KAYLA","nickname":null,"middle_name":null,"last_name":"MCFEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140214,"prefix":null,"prefix_display":null,"first_name":"KATE","nickname":null,"middle_name":null,"last_name":"ILAHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150625,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2484 Seniors Access to Critical Medications Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 2626 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41242,"prefix":"mr","prefix_display":"MR.","first_name":"KEVIN","nickname":null,"middle_name":"N","last_name":"NICHOLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":16508,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"C","last_name":"ANDERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65079,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"TIGHE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101990,"prefix":null,"prefix_display":null,"first_name":"CHRISTIE","nickname":null,"middle_name":"R.","last_name":"BOUTTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138115,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"PATRICK","last_name":"KRESE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":108774,"prefix":null,"prefix_display":null,"first_name":"KAYLA","nickname":null,"middle_name":null,"last_name":"MCFEELY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140214,"prefix":null,"prefix_display":null,"first_name":"KATE","nickname":null,"middle_name":null,"last_name":"ILAHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150625,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"KATZ","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/956076c6-86a3-42ed-bf18-8375d3295b7b/","filing_uuid":"956076c6-86a3-42ed-bf18-8375d3295b7b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/956076c6-86a3-42ed-bf18-8375d3295b7b/print/","filing_document_content_type":"text/html","income":null,"expenses":"7360000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Paul J. Larsen","dt_posted":"2026-07-20T15:46:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"670 Maine Avenue, SW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":31350,"url":"https://lda.gov/api/v1/registrants/31350/","house_registrant_id":30654,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","description":null,"address_1":"670 Maine Avenue, SW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL J. LARSEN","contact_telephone":"+1 202-835-3400","dt_updated":"2026-07-30T11:08:37.463508-04:00"},"client":{"id":138226,"url":"https://lda.gov/api/v1/clients/138226/","client_id":12,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S.___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S.___: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S.___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37) S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Presidents Budget Fiscal Year 2027 Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act H.R. 9661: Expedited Access to Biosimilars Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149775,"prefix":null,"prefix_display":null,"first_name":"JAKE","nickname":null,"middle_name":null,"last_name":"FREED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62437,"prefix":null,"prefix_display":null,"first_name":"SYLVIA","nickname":null,"middle_name":null,"last_name":"YU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41615,"prefix":null,"prefix_display":null,"first_name":"RANDY","nickname":null,"middle_name":null,"last_name":"BURKHOLDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142246,"prefix":null,"prefix_display":null,"first_name":"JUDITH","nickname":null,"middle_name":null,"last_name":"HARON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146239,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"JEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147771,"prefix":null,"prefix_display":null,"first_name":"NIELAH","nickname":null,"middle_name":null,"last_name":"TUCKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 6089: Biomanufacturing Excellence Act of 2025 H.R. 9102: Biotech Investment National Security Act of 2026 (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152549,"prefix":null,"prefix_display":null,"first_name":"MEREDITH","nickname":null,"middle_name":null,"last_name":"ALLISON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68966,"prefix":null,"prefix_display":null,"first_name":"TERESA","nickname":null,"middle_name":null,"last_name":"BILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145357,"prefix":"ms","prefix_display":"MS.","first_name":"ELENORA","nickname":"NORA","middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146964,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":"JANE","last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67006,"prefix":null,"prefix_display":null,"first_name":"BART","nickname":null,"middle_name":null,"last_name":"FORSYTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152548,"prefix":null,"prefix_display":null,"first_name":"SAMANTHA","nickname":null,"middle_name":null,"last_name":"HELTON ABBOUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":29387,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146241,"prefix":null,"prefix_display":null,"first_name":"FABIAN","nickname":null,"middle_name":null,"last_name":"LUCERO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":112885,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"NAPPI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139422,"prefix":"mr","prefix_display":"MR.","first_name":"TOM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150986,"prefix":"ms","prefix_display":"MS.","first_name":"MARIA","nickname":null,"middle_name":"PATTERSON","last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18361,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"REILLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140503,"prefix":null,"prefix_display":null,"first_name":"ZACH","nickname":null,"middle_name":null,"last_name":"SENTEMENTES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140502,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41619,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66321,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"GOLDBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139656,"prefix":null,"prefix_display":null,"first_name":"JOCELYN","nickname":null,"middle_name":null,"last_name":"ULRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154901,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"JUDE","last_name":"DILORETO","suffix":null,"suffix_display":null},"covered_position":"None","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e2da4764-9942-4a58-bb71-5df6a3fc754f/","filing_uuid":"e2da4764-9942-4a58-bb71-5df6a3fc754f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e2da4764-9942-4a58-bb71-5df6a3fc754f/print/","filing_document_content_type":"text/html","income":null,"expenses":"2440000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jesse Kerns","dt_posted":"2026-07-20T16:02:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":3867,"url":"https://lda.gov/api/v1/registrants/3867/","house_registrant_id":31560,"name":"AMGEN, INC.","description":null,"address_1":"601 13th Street, NW","address_2":"11th Floor North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREG PORTNER","contact_telephone":"+1 202-585-9500","dt_updated":"2026-07-30T12:38:37.840722-04:00"},"client":{"id":103709,"url":"https://lda.gov/api/v1/clients/103709/","client_id":12,"name":"AMGEN INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 HR 8800 National Defense Authorization Act for Fiscal year 2027 HR 9102 BINSA Bill COINS Act, enacted within P.L. 119-60 National Defense Authorization Act for Fiscal Year 2026 S 1414 Expedited Access to Biosimilars Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment S.3345, PBM Price Transparency and Accountability Act HR 6166, Lowering Drug Costs for American Families Act S 3019 - No Big Blockbuster Bailouts Act S 3349 PBM Disclosure Act HR 4317 PBM Reform Act Issues related to Public law 117-1769 Inflation Reduction Act HR 1672 Maintaining Investments in New Innovation Act (MINI) HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 PL 119-75 Consolidated Appropriations Act of 2026 HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international tax Public Law 115-97, Tax Cuts and Jobs Act Public Law 119-21, One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) Issues related to Puerto Rico Issues related to OECD negotiations on the taxation of global income","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/4212107a-6ca7-45b4-a24a-54a44efcc8df/","filing_uuid":"4212107a-6ca7-45b4-a24a-54a44efcc8df","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/4212107a-6ca7-45b4-a24a-54a44efcc8df/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Tim Casey","dt_posted":"2026-07-20T17:02:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12601 Twinbrook Parkway","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":400358632,"url":"https://lda.gov/api/v1/registrants/400358632/","house_registrant_id":null,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","description":"Public health organization","address_1":"12601 Twinbrook Parkway","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY P. LAKAVAGE","contact_telephone":"+1 301-816-8334","dt_updated":"2026-07-30T11:25:36.781811-04:00"},"client":{"id":189520,"url":"https://lda.gov/api/v1/clients/189520/","client_id":12,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/088563e1-4a43-4ca5-af99-2ec9ae411253/","filing_uuid":"088563e1-4a43-4ca5-af99-2ec9ae411253","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/088563e1-4a43-4ca5-af99-2ec9ae411253/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Tim Casey","dt_posted":"2026-07-20T17:07:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"12601 Twinbrook Parkway","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":400358632,"url":"https://lda.gov/api/v1/registrants/400358632/","house_registrant_id":null,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","description":"Public health organization","address_1":"12601 Twinbrook Parkway","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY P. LAKAVAGE","contact_telephone":"+1 301-816-8334","dt_updated":"2026-07-30T11:25:36.781811-04:00"},"client":{"id":189520,"url":"https://lda.gov/api/v1/clients/189520/","client_id":12,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151460,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"J","last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/41ec25f3-1302-434f-9280-defab2586c33/","filing_uuid":"41ec25f3-1302-434f-9280-defab2586c33","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/41ec25f3-1302-434f-9280-defab2586c33/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mary Beth Savary Taylor","dt_posted":"2026-07-20T17:10:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":213700,"url":"https://lda.gov/api/v1/clients/213700/","client_id":1005608,"name":"AMGEN","general_description":"Biotechnology.","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitored implementation of P.L. 117-169, the Inflation Reduction Act as it relates to drug pricing. Issues related to biosimilars. Monitored issues related to cardiovascular health. Issues related to pharmacy benefit management. Monitored issues related to dialysis services. Issues related to the Most Favored Nation drug pricing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to pharmacy benefit management. Issues related to cardiovascular care. Issues related to drug pricing. Issues related to the drug supply chain. S. 3788, Clear Labels Act. S. 3014, Ensuring Timely Access to Generics Act of 2025; S. 1954, Biosimilar Red Tape Elimination Act; S. 2658, Medication Affordability and Patent Integrity Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Monitored issues related to intellectual property.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51079,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"CHOUDHRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs. Issues related to drug pricing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150500,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FROMM","suffix":null,"suffix_display":null},"covered_position":"(continued) U.S. House Cmte on Oversight and Government Reform, Deputy General Counsel, Parliamentarian, Professional Staff Member; U.S. Rep. Darrell Issa, Leg. Asst., Leg. Corr., Staff Asst., Intern","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d8ca7ec3-fb33-4e4a-af45-068cb33d1ee3/","filing_uuid":"d8ca7ec3-fb33-4e4a-af45-068cb33d1ee3","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d8ca7ec3-fb33-4e4a-af45-068cb33d1ee3/print/","filing_document_content_type":"text/html","income":null,"expenses":"320000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Anne O. Riser","dt_posted":"2026-07-20T17:19:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"200 MASSACHUSETTS AVENUE, NW","registrant_address_2":"SUITE 310","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":7554,"url":"https://lda.gov/api/v1/registrants/7554/","house_registrant_id":31585,"name":"BUSINESS SOFTWARE ALLIANCE","description":null,"address_1":"200 MASSACHUSETTS AVENUE, NW","address_2":"SUITE 310","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNE RISER","contact_telephone":"+1 202-530-5148","dt_updated":"2026-07-16T15:45:10.679271-04:00"},"client":{"id":110754,"url":"https://lda.gov/api/v1/clients/110754/","client_id":12,"name":"BUSINESS SOFTWARE ALLIANCE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-30"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"National Defense Authorization Act generally, and including the House FY26 NDAA, S. 2296 - the Senate FY26 NDAA, S. 4784 - National Defense Authorization Act for Fiscal Year 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145016,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"SALMOIRAGHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Domestic law enforcement access to digital evidence generally, S. 3663/H.R. 6048 NDO Fairness Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Issues pertaining to workforce development and retraining issues, S. 2976 - Halting International Relocation of Employment (HIRE) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"INT","general_issue_code_display":"Intelligence","description":"Issues related to intelligence community surveillance of electronic communications","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues pertaining to market access for software products and services in international markets including, but not limited to, provisions related to intellectual property protection and market access for software products and services, S. 3399 - Digital Trade Promotion Act of 2025 Issues pertaining to international trade agreements including, but not limited to, provisions relating to IP protection and enforcement, electronic commerce, services and government procurement, including H.R. 2683 - Remote Access Security Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPI","general_issue_code_display":"Computer Industry","description":"Issues related to modernization of government technology generally, including FedRAMP Issues related to quantum technology, including S. 1344/H.R. 3220 - Quantum Sandbox for Near-Term Applications Act of 2025, S. 1746 - Quantum LEAP Act of 2025, H.R. 3788 - Support for Quantum Supply Chains Act, S. 2558 - The National Quantum Cybersecurity Migration Strategy Act of 2025, H.R. 4942 - Quantum Encryption Readiness and Resilience Act, S.3597 National Quantum Initiative Reauthorization Act of 2026 Issues pertaining to Cybersecurity generally, and including H.R. 1000 - Cyber PIVOTT Act, S. 1337 - Cybersecurity Information Sharing Extension Act Issues pertaining to the development of Artificial Intelligence generally, and specifically, S. 146 - TAKE IT DOWN Act, H.R. 633 - TAKE IT DOWN Act, H.R. 2385 - CREATE AI Act, S. 1792 - AI Whistleblower Protection Act, S. 2081 - RISE Act of 2025, H.R. 4142 - Adversarial AI Act of 2025, S. 2750 - SANDBOX Act, S. 3150 - GAIN AI Act, H.R. 6875 - Overwatch AI Act, H.R.8516 - American Leadership in AI Act, H.R. 9442 - Artificial Intelligence Data Center Moratorium Act Issues pertaining to government procurement of software generally, and including the FoRGED Act, the Safeguarding American Innovation Act, H.R. 2417 - Strengthening Agency Management and Oversight of Software Assets Act, S. 1362/H.R. 2765 - SAFE Supply Chains Act, H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery (SPEED) Act, H.R. 3961 - Safeguarding American Innovation Act, H.R. 7604 Contracting America First Act, H.R. 8189 - American Security Robotics Act, S. 4570 - U.S. Tech PATH Act Comprehensive federal privacy legislation, generally and including S. 836 - Children and Teens Online Privacy Protection Act, S. 1748 - Kids Online Safety Act, H.R.8413 - Secure Data Act Issues pertaining to content moderation and Section 230 generally","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145016,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"SALMOIRAGHI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues pertaining to intellectual property rights including, but not limited to, patent protection and enforcement, copyright protection and enforcement in international markets, and including S. 1553 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60231,"prefix":null,"prefix_display":null,"first_name":"CRAIG","nickname":null,"middle_name":null,"last_name":"ALBRIGHT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141209,"prefix":null,"prefix_display":null,"first_name":"DANIELLE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140485,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":207,"name":"U.S. Copyright Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/85d0f018-b51b-48f7-acbd-f24be2818753/","filing_uuid":"85d0f018-b51b-48f7-acbd-f24be2818753","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/85d0f018-b51b-48f7-acbd-f24be2818753/print/","filing_document_content_type":"text/html","income":null,"expenses":"1820000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Parrish","dt_posted":"2026-07-20T17:25:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Ave., NW Suite 900","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":5632,"url":"https://lda.gov/api/v1/registrants/5632/","house_registrant_id":31257,"name":"BAYER CORPORATION (CONSOLIDATED REPORT)","description":null,"address_1":"801 Pennsylvania Ave., NW Suite 900","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL PARRISH","contact_telephone":"+1 202-737-8900","dt_updated":"2026-07-30T15:08:38.983388-04:00"},"client":{"id":107401,"url":"https://lda.gov/api/v1/clients/107401/","client_id":12,"name":"BAYER CORPORATION (CONSOLIDATED REPORT)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Monitor and engage on legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor and engage on legislative and administrative action related to the Endangered Species Act and related reforms. Monitor and engage on legislative and administrative action related to 7 CFR Part 340. Monitor and engage on legislative and administrative action related to biotech innovation and regulation. Monitor and engage on legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor and engage on legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor and engage on legislative and administrative action related to food security and nutrition. Monitor and engage on legislative and administrative action related to biofuels, including ethanol, the RFS, and sustainable aviation fuel. Monitor and engage on legislative and administrative action related to Pesticides: Exemptions of Certain Plant-Incorporated Protectants Derived from Newer Technologies (Final Rule). Monitor and engage on legislative and administrative action related to reauthorization of Foundation for Food and Agriculture Research (FFAR). Monitor and engage on legislative and administrative action related to the Farm Bill reauthorization. Monitor and engage on legislative and administrative action related to Ag chemistry. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21). H.R. 7567, Farm, Food and National Security Act of 2026, including Section 10205 -- Uniformity of Pesticide Labeling Requirements. S. 3122, Better Food Disclosure Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":15,"name":"Council on Environmental Quality (CEQ)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitor and engage on legislative and administrative action on appropriations and budget. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to FY2027 Interior, Environment, and Related Agencies Appropriations Acts. Monitor and engage on legislative and administrative action related to FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts. H.R. 9171, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027. H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Sen. Al Franken (01/15-11/15)","new":true}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Sen. Al Franken (01/15-11/15)","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitor and engage on legislative and administrative action related to Medicare and Medicaid policy. Monitor the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169). Monitor and engage on legislative and administrative action related to Medicare inpatient reimbursement for cell and gene therapies. H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Sen. Al Franken (01/15-11/15)","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Monitor and engage on legislative and administrative action related to Section 301 tariffs. Monitor and engage on legislative and administrative action related to tariff deferment. Monitor and engage on legislative and administrative action related to tariff suspensions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitor and engage on legislative and federal activity related to tax reform. Monitor and engage on legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor and engage on legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor and engage on legislative and administrative issues related to foreign tax credit regulations. Monitor and engage on the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169), including the section 45Z tax credit and the sustainable aviation fuel tax credit. Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Sen. Al Franken (01/15-11/15)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Monitor and engage on legislative and administrative action related to trade. Monitor and engage on legislative and administrative action related to foreign regulation of chemicals, pesticides, pharmaceuticals, and health care products. Monitor and engage on legislative and administrative action related to China import approvals, and foreign direct investment prohibitions and restrictions. Monitor and engage in administrative action related to maximum residue levels (MRLs) in the ASEAN region. Monitor and engage on legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor and engage on legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor and engage on legislative and administrative action related to Korea import approvals. Monitor and engage on legislative and administrative action related to intellectual property issues and regulations in India. Monitor and engage on legislative and administrative action related to World Trade Organization (WTO) digital trade rules. Monitor and engage on legislative and administrative action related to Section 301 tariffs. Monitor and engage on legislative and administrative action related to Section 232 tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":41,"name":"Treasury, Dept of"},{"id":196,"name":"U.S. Agency for International Development (USAID)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Monitor and engage on legislative and administrative action related to Biofuels and the Renewable Fuel Standard. Monitor and engage on the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). Monitor and engage on the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"NAT","general_issue_code_display":"Natural Resources","description":"Monitor and engage on legislative and administrative action related to phosphate mining operations and permits. Monitor and engage on legislative and administrative action related to the Endangered Species Act. Monitor and engage on legislative and administrative action related to the Fairness and Certainty in Reclamation Act (no bill number yet). H.R. 1897, ESA Amendments Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":148,"name":"Bureau of Land Management (BLM)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":144,"name":"U.S. Geological Survey (USGS)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Monitor and engage on legislative and administrative action related to climate change, including sustainable agriculture. Monitor and engage on legislative and administrative action related to FIFRA Regulations, including voluntary carbon markets. Monitor and engage on legislative and administrative action related to the Endangered Species Act. H.R. 1897, ESA Amendments Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Monitor and engage on legislative and administrative action related to antitrust and competition.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/849f4eac-0048-40cc-8064-2aa417e1266e/","filing_uuid":"849f4eac-0048-40cc-8064-2aa417e1266e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/849f4eac-0048-40cc-8064-2aa417e1266e/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Diane Major","dt_posted":"2026-10-03T14:14:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Ave., NW, Suite 300","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington, DC","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401103162,"url":"https://lda.gov/api/v1/registrants/401103162/","house_registrant_id":null,"name":"THE D MAJOR GROUP","description":"Government affairs consulting","address_1":"300 New Jersey Ave., NW, Suite 300","address_2":null,"address_3":null,"address_4":null,"city":"Washington, DC","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DIANE MAJOR","contact_telephone":"+1 202-695-0635","dt_updated":"2026-07-14T14:03:47.385236-04:00"},"client":{"id":198055,"url":"https://lda.gov/api/v1/clients/198055/","client_id":63,"name":"HEALTH CARE SUPPLY CHAIN ASSOCIATION","general_description":"Trade association representing healthcare provider group purchasing organizations.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-10-28"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Work on incentives for onshore manufacturing, in addition to an emergency exemption for critical medical supplies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Sen. Repub. Policy Com't.","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conf.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Work on protection of the Medicare safe harbor and its savings to the health care delivery system.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Senate Republican Policy Committee","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conference","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Work on drug shortage issues affecting outpatient and inpatient settings. Also work on drug visibility supply chain issues including S. 3788, \"the CLEAR Labels Act.\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59606,"prefix":null,"prefix_display":null,"first_name":"DIANE","nickname":null,"middle_name":null,"last_name":"MAJOR","suffix":null,"suffix_display":null},"covered_position":"Health Policy Analyst for Senate Republican Policy Committee","new":false},{"lobbyist":{"id":60176,"prefix":null,"prefix_display":null,"first_name":"BRENDA","nickname":null,"middle_name":null,"last_name":"REESE","suffix":null,"suffix_display":null},"covered_position":"Conference Coordinator for House Republican Conference","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a6ae1dd0-ae25-46a8-a17a-ce5a7a0aa3fa/","filing_uuid":"a6ae1dd0-ae25-46a8-a17a-ce5a7a0aa3fa","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a6ae1dd0-ae25-46a8-a17a-ce5a7a0aa3fa/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Gary Gallant","dt_posted":"2026-10-13T11:49:52-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"253 36th Street","registrant_address_2":"STE C663","registrant_different_address":false,"registrant_city":"Brooklyn","registrant_state":"NY","registrant_zip":"11232","registrant":{"id":401110201,"url":"https://lda.gov/api/v1/registrants/401110201/","house_registrant_id":77363,"name":"BLUEFORS INC.","description":null,"address_1":"253 36th Street","address_2":"STE C663","address_3":null,"address_4":null,"city":"Brooklyn","state":"NY","state_display":"New York","zip":"11232","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GARY GALLANT","contact_telephone":"+1 202-492-3636","dt_updated":"2026-07-15T08:51:55.140473-04:00"},"client":{"id":70814,"url":"https://lda.gov/api/v1/clients/70814/","client_id":70814,"name":"BLUEFORS INC.","general_description":"Cryogenics Technology Supplier","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-01-01"},"lobbying_activities":[{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Encouraging further cryogenic workforce and manufacturing capacity in the United States, including provisions in S. 1343, the Advancing Quantum Manufacturing Act of 2025 and S. 579, the Department of Energy Quantum Leadership Act of 2025.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"CPI","general_issue_code_display":"Computer Industry","description":"Quantum computing as related to cloud infrastructure.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Quantum cryptography research and application matters, including provisions in S. 3597, the National Quantum Initiative Reauthorization act of 2026. Executive Order 14412 - Securing the Nation Against Advanced Cryptographic Attacks. Reauthorization provisions of the National Quantum Initiative in the FY2027 National Defense Authorization Act (NDAA).","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"Quantum cryptography research and application matters, including provisions in S. 3597, the National Quantum Initiative Reauthorization act of 2026. Executive Order 14412 - Securing the Nation Against Advanced Cryptographic Attacks.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":150,"name":"Federal Bureau of Investigation (FBI)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Quantum computing policy and research, including provisions in S. 579 - Department of Energy Quantum Leadership Act of 2025, S. 1746/HR 5712 - Quantum LEAP Act of 2025, S. 4163/H.R. 6351 - Advancing Regional Quantum Hubs Act, S. 1397 - International Quantum Research Exchange Act, S. 1343 - Advancing Quantum Manufacturing Act of 2025, H.R. 3788 - Support for Quantum Supply Chains Act, S. 3597 - National Quantum Initiative Reauthorization Act of 2026, and S. 579, the Department of Energy Quantum Leadership Act of 2025. Executive Order 14413 \"Ushering in the Next Frontier of Quantum Innovation\"","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Trade and bilateral discussions with Finland. Tariffs on inputs and finished goods.","foreign_entity_issues":"Bluefors OY, as the parent entity, has an interest in this general issue area.","lobbyists":[{"lobbyist":{"id":152899,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"BLUME","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}